The Institute of Cancer Research shared on LinkedIn:
“‘I have a better quality of life thanks to capivasertib.’
Sue, 61, was diagnosed with breast cancer at the age of 51.
Following several years in remission, her cancer returned and spread to her liver.
In December 2025, she began treatment with the drug capivasertib, the discovery and development of which was underpinned by research at The Institute of Cancer Research.
Since then, her cancer markers have come down, her latest scan shows her cancer is stable, and she is living life to the full.
‘It is scary to think my cancer is not curable, but now I am back to leading a normal life. I can walk my dog, go out with friends, I’ve taken up new hobbies.
I can now look for the good in things, feel positive and enjoy life a bit more.
‘I am grateful to cancer research for the life I still have.
It is vital – and without it, I would not be here.
Cancer research allows me to feel hopeful and to believe in the possibilities of new treatments and discoveries that will come about in the future.’
We are proud to be at the forefront of new discoveries that help cancer patients live longer, better lives.”
Other articles about breast cancer on OncoDaily.